Allumiqs Names Derek Gooderham President
Halifax, NS – December 10, 2025 – Allumiqs is pleased to announce the appointment of Derek Gooderham as President of the Company to lead all…
How Flexible Access to Advanced Proteomics Instrumentation and Expertise Tranforms Research Timelines
By partnering with Allumiqs and leveraging their innovative Time Blocks procurement model, the company improved their research workflow, eliminated processing bottlenecks, and gained greater insights…
State-of-the-Art Proteomics Solutions for Knockout Cell Line Validation
With customized LC-MS workflows and data visualization, the company improved their validation accuracy and deepened customer confidence in their research solutions.
Tailor-Made Proteomics Solutions for a Biotech Startup
The startup gained access to the proteomics expertise and LC-MS skills necessary tomake smarter decisions about the direction of their research.
Allumiqs and RayBiotech Forge Strategic Alliance to Advance Translational Biomarker Research
This collaboration bridges advanced proteomics with multiomics analytics, enabling researchers to move seamlessly from discovery to clinic.
How Flexible Proteomics Analysis Services Helped a Biotech Startup Overcome Research Hurdles
Through partnership with Allumiqs and its Time Blocks procurement model, they gained access to the advanced LC-MS capabilities they needed without committing to high-riskcapital investments.…
Allumiqs Enhances Advanced Biomarker Discovery Capabilities with Alamar’s ARGO™ HT System
Allumiqs is strengthening its customer solutions with capabilities in detecting and quantifying proteins at unprecedented levels of sensitivity and accuracy.
New partnership to accelerate scientific innovation
Allumiqs is excited to announce a new strategic partnership with The Research Institute of McGill University Health Centre (The Institute), a world-renowned biomedical and healthcare…
Allumiqs Announces Derek Gooderham’s Appointment to Board of Directors
Halifax, Nova Scotia, September 16, 2024 – Allumiqs, a tech-enabled multiomics contract research organization (CRO), today announced the appointment of Derek Gooderham to its Board…
Allumiqs expands metabolomics solutions as part of the biocrates Certified Laboratory Program
Allumiqs announced today that it is now a member of the biocrates Certified Laboratory Program, becoming the only Contract Research Organization (CRO) in North America…